Summit Therapeutics Inc
Summit Therapeutics is a biopharmaceutical company focused on developing new antibiotic treatments for resistant bacterial infections and other serious diseases.
Price history of Summit Therapeutics Inc
Price history of Summit Therapeutics Inc
Performance & Momentum
Strategic Analysis
Summit Therapeutics Inc • 2026
Summit Therapeutics is a biopharmaceutical company focused on developing innovative treatments, with a positioning centered on oncology and infectious diseases. Its value proposition is primarily based on value creation through clinical trials, with the typical profile of a research company offering significant upside in the event of regulatory or therapeutic success.
- Exposure to oncology, a healthcare segment with strong economic and scientific potential
- Value creation model driven mainly by clinical progress and development catalysts
- Long-term stock market history showing an ability to generate strong re-ratings during periods of market confidence
- High dependence on the success of clinical trials and regulatory decisions
- Significant volatility profile, with recent performance weaker than its long-term history
Momentum is moderate and reflects an still constructive dynamic, but without a sign of strong sustained acceleration at this stage. The recent trend remains mixed, with a partial rebound over several months but an annual comparison that is still negative, which suggests a selective positioning focused on upcoming clinical catalysts.
Similar stocks to Summit Therapeutics Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
